Moreover, the study established G3BP1, JAK2, and p-STAT3 as powerful prognostic markers, with G3BP1's expression standing as an independent indicator of poorer outcomes for NPC patients. The gene discussed is JAK2; the disease is nasopharyngeal carcinoma.